Governance of Biobanks for Cancer Research: Proposal for a Material Transfer Agreement

  • Barbara ParodiEmail author
  • Paola Visconti
  • Tiziana Ruzzon
  • Mauro Truini


In this article, we discuss some of the features and some of the open issues of a model for a Material Transfer Agreement (MTA) which could be used by biobanks for cancer research.


Intellectual Property Generic Clause Material Transfer Agreement Inactivate Polio Vaccine Public Research Centre 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Cambon-Thomsen A, Thorisson GA, Mabile L (2011) The role of a bioresource research impact factor as an incentive to share human bioresources. Nat Genet 43(6):503–504CrossRefGoogle Scholar
  2. Dove A (2002) When science rides the MTA. J Clin Invest 110(4):425–427Google Scholar
  3. Editorials Nature (September 2009) Biobanks Need Pharma. Vol. 461, 24 September 2009Google Scholar
  4. Kaye J, Heeney C, Hawkins N, de Vries J, Boddington P (2009) Data sharing in genomics. re-shaping scientific practice. Nat Rev Genet 10:331–335CrossRefGoogle Scholar
  5. OECD (2007) Best practice guidelines for biological resource centres. Accessed 25 Mar 2012
  6. Streitz WD, Bennett AB (2003) Material transfer agreements: a university perspective. Plant Physiol 133(1):10–13CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Barbara Parodi
    • 1
    Email author
  • Paola Visconti
    • 1
  • Tiziana Ruzzon
    • 2
  • Mauro Truini
    • 3
  1. 1.Biobank and cell factory unit IRCCS San Martino – ISTGenoaItaly
  2. 2.Office of Technological Transfer and Coordination of Core Facilities IRCCS San Martino – ISTGenoaItaly
  3. 3.Anatomia e citoistologia patologica – IRCCS San Martino – ISTGenoaItaly

Personalised recommendations